OXYGENTA PHARMACEUTICAL LIMITE Share Price

BSE: 524636
|
Pharmaceuticals

₹ 47.08

-₹0.01 (-0.02%)
1D
Last updated 14 Oct, 2026, 15:11 IST

OXYGENTA PHARMACEUTICAL LIMITE Share Price Today

As of 14 Oct 2026, OXYGENTA PHARMACEUTICAL LIMITE share price is ₹47.08. The stock opened at ₹47.08, compared to its previous close of ₹47.09. During today's trading session, OXYGENTA PHARMACEUTICAL LIMITE share price moved in the range of ₹46.61 to ₹47.09, with an average price of ₹46.85 for the day. Looking at its last 52-week, the stock has touched a low of ₹43.00 and a high of ₹71.59.

₹46.61
0.02% down today
₹47.09
1D LOW
1D HIGH

OXYGENTA PHARMACEUTICAL LIMITE Returns Calculator

Volume
4,543
Average traded price
₹47.04
Last traded time
03:11:11 14 Oct
Last traded quantity
100
Circuit
L
H
₹44.74
₹49.44
52-week
L
H
₹43.00
₹71.59
Mkt Cap Cr
174.16
P/E
-12.83
P/B
-4.19
ROA
-11.34%
ROE
41.16%
ROCE
-26.02%
Quick Ratio
0.26
EV/EBITDA
-36.53
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Oxygenta Pharma has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Oxygenta Pharma appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0135.035.0811.19%13.74%17.33%2.3121.42
Divis Laboratories2,46,222.1184.1814.6914.6%15.32%19.56%3.556.81
Torrent Pharmaceuticals1,76,300.5081.7720.964.87%25.49%13.85%0.7538.3
Zydus Lifesciences1,12,817.6824.574.168.57%18.59%17.35%0.9115.07
Laurus Labs1,11,898.66101.6420.9110.38%16.77%16.14%0.6854.71
Cipla1,06,129.9632.023.127.92%11.27%14.95%2.517.97
Dr. Reddy's Laboratories1,03,471.1432.52.725.48%11.07%12.54%1.3516.27
Mankind Pharma99,089.5247.326.07.36%11.74%13.13%0.7426.02
Aurobindo Pharma96,836.1026.12.566.34%9.25%11.76%1.1512.57
Lupin89,628.8316.153.9914.47%23.76%24.88%1.429.46

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About OXYGENTA PHARMACEUTICAL LIMITE

ISIN
INE102E01018
Sector Market Cap
₹ 174.16 Cr

Oxygenta Pharmaceutical Limited is an India-based company engaged in the manufacturing and selling of pharmaceutical, medical and veterinary preparations. It operates in the pharmaceutical segment. The Company also sells the products to its related companies engaged in the manufacture of formulations. Its active pharmaceutical ingredients (API) products include pantoprazole sodium, vildagliptin, telmisartan, lacosamide, and sertraline hydrochloride. The Company’s chemical products include 3-Amino-1-adamantanol, (S)-1-(2-Chloroacetyl) pyrrolidine-2-carbonitrile, 2-N-Propyl-4-methyl-6-(1-methyl benzimidazole-2-yl) benzimidazole, Isobutyramide, 4-Aminobenzonitrile, Valeronitrile and others. Its manufacturing facilities are situated at Sadasivapet Mandal, Sangareddy District, Telangana State.

OXYGENTA PHARMACEUTICAL LIMITE Financial Highlights

  • Revenue: OXYGENTA PHARMACEUTICAL LIMITE reported revenue of ₹113.27 crore in FY26 vs ₹110.61 crore in FY25. It showed an increase of 2.40% on a yearly basis.
  • Operating Profit: OXYGENTA PHARMACEUTICAL LIMITE reported an operating loss of ₹22.18 crore in FY26 vs ₹14.35 crore in FY25. It showed a decrease of 54.56% on a year-on-year basis.
  • Net Profit: OXYGENTA PHARMACEUTICAL LIMITE reported a net loss of ₹17.57 crore in FY26 vs ₹10.30 crore in FY25. It showed a decrease of 70.58% on a yearly basis.

OXYGENTA PHARMACEUTICAL LIMITE Quarterly Result Highlights

  • OXYGENTA PHARMACEUTICAL LIMITE reported revenue of ₹37.02 crore in Jun 2026, compared with ₹49.78 crore in Mar 2026, representing a decrease of 25.63% on a quarter-on-quarter (QoQ) basis.
  • OXYGENTA PHARMACEUTICAL LIMITE reported an operating loss of ₹2.51 crore in Jun 2026, compared with ₹1.28 crore in Mar 2026, representing a decrease of 96.09% on a quarter-on-quarter (QoQ) basis.
  • OXYGENTA PHARMACEUTICAL LIMITE reported a loss of ₹2.10 crore in Jun 2026, compared with ₹1.70 crore in Mar 2026, reflecting a decrease of 23.53% on a QoQ basis.
  • The earnings per share (EPS) of OXYGENTA PHARMACEUTICAL LIMITE stood at ₹4.75 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
56.54%
FII
0.00%
Other DII
0.00%
Retail and other
43.44%
Mutual funds
0.03%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
1 day
-0.02%
1 week
-1.67%
1 month
-15.75%
1 year
-17.37%
3 years
+58.31%
5 years
+50.18%
Day
Open / Close
Change %
13 Oct 26
₹47.53 / ₹47.09
-2.91%
12 Oct 26
₹47.55 / ₹48.50
-0.21%
09 Oct 26
₹48.74 / ₹48.60
+1.91%
08 Oct 26
₹47.99 / ₹47.69
-0.40%
Show more

OXYGENTA PHARMACEUTICAL LIMITE Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹112.98₹109.30₹39.64₹30.99
Other Income₹0.29₹1.31₹0.04₹0.02
Total Revenue₹113.27₹110.61₹39.68₹31.01
Total Expenses₹135.45₹124.96₹53.59₹41.64
Profit Before Tax-₹22.18-₹14.35-₹13.87-₹11.37
Tax-₹4.61-₹4.05-₹10.39₹0.20
Profit After Tax-₹17.57-₹10.30-₹3.48-₹11.57
EPS - Basic-₹4.75-₹2.86-₹1.09-₹8.15
EPS - Diluted-₹4.75-₹2.86-₹1.04-₹8.15

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹22.18-₹14.35-₹13.87-₹11.37
Income before WC changes-₹14.15-₹7.75-₹9.56-₹7.84
Change in Assets-₹19.41-₹7.63₹1.25-₹15.54
Change in Liabilities₹5.65₹18.21-₹4.73₹21.75
Change in WC-₹13.76₹10.58-₹3.49₹6.20
Cash flow from Operations-₹27.75₹2.83-₹13.05-₹1.63
Cash flow from Investing-₹14.39-₹11.32-₹4.09-₹9.64
Cash flow from Financing₹42.56₹8.49₹17.13₹11.22
Total Cash Flow₹0.42₹0.00-₹0.01-₹0.05
Cash (Start of the year)₹0.00₹0.00₹0.11₹0.16
Cash (End of the year)₹0.42₹0.00₹0.10₹0.11

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹68.25₹51.86₹39.09₹29.26
Current Assets₹51.43₹30.94₹24.11₹25.01
Total Assets₹119.68₹82.80₹63.19₹54.26
Current Liabilities₹86.10₹85.85₹33.70₹32.90
Net Current Asset-₹34.67-₹54.90-₹9.59-₹7.89
Non-Current Liabilities₹76.27₹22.60₹49.62₹67.57
Equity Capital-₹42.69-₹25.64-₹20.12-₹46.20
Total Equity & Liabilities₹119.68₹82.80₹63.19₹54.26
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
47.08
100
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 100
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
34.5
Neutral
ATR (14)
1.87
Neutral
STOCH(9,6)
33.02
Neutral
STOCH RSI (14)
45.07
Neutral
ADX(9)
49.13
Bearish
UO(9)
50.26
Neutral
ROC(12)
-7.32
Bearish
WillR(14)
-80.6
Bullish
Period
Simple value
Exponential vaue
5D
47.95
47.85
10D
47.86
48.3
20D
49.65
49.77
50D
54.88
52.05
100D
52.05
52.82
Volume trend — traded volume by day
14 Oct0L
13 Oct0L
12 Oct0L
9 Oct0L
8 Oct0L
7 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
OXYGENTA PHARMACEUTICAL LIMITE
Pharmaceuticals
Add Stock
Add Another

OXYGENTA PHARMACEUTICAL LIMITE Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.